Feng Tian | Cancer Biophotonics Studies | Best Researcher Award

Prof. Dr. Feng Tian | Cancer Biophotonics Studies | Best Researcher Award

Prof. Dr. Feng Tian, Hebei University of Engineering, China 

Dr. Feng Tian, Ph.D., is a distinguished Professor of Bioinformatics and Medical Data Science at the School of Medicine, Hebei University of Engineering. With over two decades of academic and research excellence, Dr. Tian has established himself as a pioneer in integrating artificial intelligence, bioinformatics, and public health data science. His interdisciplinary expertise drives cutting-edge solutions across clinical diagnostics, multi-omics research, and emergency medical services.

Profile 

Scopus

🎓 Early Academic Pursuits

Dr. Tian earned both his Bachelor’s degree in Biology and his Ph.D. in Bioinformatics from the prestigious Tsinghua University in Beijing, one of China’s top academic institutions. During this period (2000–2009), he demonstrated exceptional promise in computational biology and systems genomics. His doctoral research laid the groundwork for his later contributions to regulatory network analysis and transcription factor dynamics.

👨‍🏫 Professional Endeavors

Dr. Tian has held the position of Professor at Hebei University of Engineering since 2021. His international outlook is marked by his tenure as a Visiting Scholar at the National Center for Data Mining, University of Illinois at Chicago (UIC), where he collaborated with globally recognized experts in biomedical informatics. He has also played a crucial role in establishing the Hebei Key Laboratory of Medical Data Science, fostering innovation at the intersection of AI and health sciences.

🔬 Contributions and Research Focus

Dr. Tian’s primary research interests include:

  • Artificial Intelligence in Health Big Data: Developing intelligent systems for disease prediction, emergency triage, and resource allocation.

  • Multi-Omics Data Integration: Focused on molecular subtyping and MRD detection in Acute Lymphoblastic Leukemia (ALL) using transcriptomic and epigenomic data.

  • Bioinformatics Platforms: Architecting data analysis systems such as miRAS and FlyNet, enabling high-throughput genomic data processing.

  • Public Health Policy Research: Evaluating healthcare accessibility and the impact of localized health interventions like the Handan “Health Cabins” model.

🌍 Impact and Influence

Dr. Tian has co-authored high-impact publications in Nature Communications, Haematologica, Advanced Science, and Bioinformatics, reflecting his global academic stature. His work has significantly advanced our understanding of ALL pathogenesis, and informed AI-based clinical workflows in China. As Principal Investigator on several multi-disciplinary projects, he has bridged the gap between academic research and real-world healthcare applications.

📊 Academic Citations

Dr. Tian’s publications have garnered substantial academic citations, particularly in areas involving gene regulatory networks, deep learning for medical text, and multi-omics disease characterization. His 2024 and 2025 papers on glucocorticoid response in leukemia and tumorigenic profiling of adrenal incidentalomas are already becoming cornerstone references in the field.

🧠 Research Skills

Dr. Tian is highly proficient in:

  • AI and Deep Learning for medical NLP and classification tasks.

  • Multi-omics Data Analysis, including single-cell transcriptomics and epigenetic landscape mapping.

  • Spatial Data Modeling for evaluating healthcare accessibility using probabilistic algorithms.

  • Cross-species genomic comparison and graph-based regulatory modeling.

These technical proficiencies underscore his rare ability to combine computational rigor with biomedical relevance.

🎓 Teaching Experience

Although his profile focuses largely on research, as a university professor, Dr. Tian contributes to the training of graduate students, supervising research projects, and likely guiding Ph.D. candidates in bioinformatics and medical data science. Expanding documentation of his mentorship impact would further highlight his academic leadership.

🏆 Awards and Honors

Dr. Tian has been the recipient of numerous national and provincial awards, including:

  • 🥇 First Prize, Hebei Provincial Science and Technology Progress Award (2024)

  • 🥈 Second Prize, Invention and Entrepreneurship Achievement Award, China Association of Inventions (2024)

  • 🥇 First Prize, Hebei Medical Science and Technology Award (2021)

  • 🥉 Third Prize, Outstanding Achievement Award in Social Sciences (2024)

These accolades validate the real-world impact and innovation of his work, both technically and socially.

🧾 Patents and Software Copyrights

Dr. Tian has secured 22 patents and software copyrights, including:

  • A patented Prehospital Emergency Information Processing Device (2021)

  • A method for AI-driven Emergency Text Classification using ChatGLM (2024)

  • A patented Site Selection Model for Emergency Medical Stations (2025)

These innovative tools have applications in emergency response, healthcare infrastructure planning, and medical informatics.

🌟 Legacy and Future Contributions

Dr. Tian is building a legacy of translational research and technological innovation. His future contributions are likely to further:

  • Shape AI-powered healthcare delivery models in China and abroad.

  • Deepen the understanding of cancer genomics through multi-omics research.

  • Influence healthcare policy through data-driven evaluations of public health programs.

As a leader in medical AI and public health informatics, he is poised to play a key role in addressing global healthcare challenges through data science and precision medicine.

Top Publications

miRAS: a data processing system for miRNA expression profiling study

  • Authors: Tian F, Zhang H, Zhang X, Song C, Xia Y, Wu Y, Liu X

  • Journal: BMC Bioinformatics

  • Year: 2007

  • Citation: BMC Bioinformatics. 2007 Aug 4;8(1):285.

A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay

  • Authors: Tian F, Wu Y, Zhou Y, Liu X, Visvikis-Siest S, Xia Y

  • Journal: Clinical Chemistry and Laboratory Medicine (Clin Chem Lab Med)

  • Year: 2008

  • Citation: Clin Chem Lab Med. 2008;46(4):486-9.

A graph model based study on regulatory impacts of transcription factors of Drosophila melanogaster and comparison across species

  • Authors: Tian F, Chen J, Bao S, Shi L, Liu X, Grossman RL

  • Journal: Biochemical and Biophysical Research Communications (Biochem Biophys Res Commun)

  • Year: 2009

  • Citation: Biochem Biophys Res Commun. 2009 Sep 4;386(4):559-62.

Flynet: a genomic resource for Drosophila melanogaster transcriptional regulatory networks

  • Authors: Tian F*, Shah PK*, Liu X, Negre N, Chen J, Karpenko O, White KP, Grossman RL
    (*Shared first authorship indicated)

  • Journal: Bioinformatics

  • Year: 2009

  • Citation: Bioinformatics. 2009 Nov 15;25(22):3001-4.

DL-PER: Deep Learning Model for Chinese Prehospital Emergency Record Classification

  • Authors: Zhang X, Zhang H, Sheng L, Tian F*
    (*Tian F listed as senior/last author)

  • Journal: IEEE Access

  • Year: 2022

  • Citation: IEEE Access, vol. 10, pp. 64638-64649, 2022.

  • DOI: 10.1109/ACCESS.2022.3179685

Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Dr. Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Research Fellow at University of Texas MD Anderson Cancer Center, United States

Dr. Sidra Naz is a dedicated physician-scientist known for her groundbreaking research in the fields of clinical medicine, public health, and epidemiology. With a strong background in medical education and research, she has contributed significantly to advancing medical knowledge through her extensive publications and collaborative projects. Dr. Naz is passionate about improving healthcare outcomes, particularly in oncology, cardiology, and neurology. Her commitment to medical research and patient care has earned her numerous accolades and recognition in the scientific community.

Profile

Google Scholar

Education 🎓

Dr. Naz completed her M.B.B.S. at Faisalabad Medical University, Pakistan, in 2017, laying the foundation for her medical expertise. She further pursued a Master of Public Health in Epidemiology at Ohio University, USA, where she honed her skills in public health research. Her continuous pursuit of knowledge has led her to collaborate with renowned institutions, enriching her understanding of complex medical conditions and their global impact.

Experience 🌟

Dr. Naz has amassed a wealth of experience through her roles at prestigious medical institutions. She currently serves as a Clinical Research Associate and Research Coordinator at the University of Texas MD Anderson Cancer Center, where she focuses on oncology research. Previously, she held a postdoctoral research fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School, contributing to neurology and hematology-oncology research. Her extensive clinical training includes externships and observerships at esteemed hospitals such as Columbia University Irving Medical Center, Duke University, and the University of Cincinnati Medical Center.

Research Interest 🔬

Dr. Naz’s research interests encompass a broad spectrum of medical fields, including oncology, cardiology, gastroenterology, and neurology. She has made significant contributions to the study of racial disparities in clinical outcomes, stroke interventions, cardiovascular diseases, and immune-related adverse events in cancer therapy. Her work in systematic reviews and meta-analyses has provided valuable insights into improving patient care and treatment strategies.

Awards & Honors 🏆

Dr. Naz’s dedication to research excellence has been recognized through numerous prestigious awards, including:

  • Paul Dudley White International Scholar Award (AHA, 2022) – Recognizing her impactful research in advancing clinical outcomes.
  • Cureus Medical Journal Laureate Award (2022) – Honoring her contributions to scientific knowledge and clinical education.
  • Expertscape Award for Excellence (2021) – Ranking her among the top 1% of global medical experts.
  • Distinguished Medical House Officer Award (2019) – Acknowledging her leadership in community health services.
  • BIDMC/Harvard Medical School Poster Presentation Award (2022) – Recognizing her innovation in medical research.

Publications 📚

Dr. Naz has authored numerous peer-reviewed journal articles and abstracts in high-impact medical journals. Some of her key publications include:

“COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review”

Year: 2021
Citations: 50

“Psychological Stress as a Risk Factor for Cardiovascular Disease: A Case-Control Study”

Year: 2020
Citations: 47

“Meningitis as an Initial Presentation of COVID-19: A Case Report”

Year: 2020
Citations: 43

“Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review”

Year: 2022
Citations: 39

“einfection of COVID-19 in Pakistan: A First Case Report”

Year: 2020
Citations: 31

“Causes of Acute Peritonitis and Its Complication”

Year: 2021
Citations: 28

“Hypovitaminosis D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis”

Year: 2022
Citations: 27

“Association Between Hypertension and Hearing Loss”

Year: 2021
Citations: 25

“Comparison of Lipid Profile in Patients With and Without Subclinical Hypothyroidism”

Year: 2021
Citations: 25

“Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome”

Year: 2021
Citations: 19

“SGLT2 Inhibitors Among Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials”

Year: 2023
Citations: 18

“COVID-19-Induced Mesenteric Thrombosis”

Year: 2021
Citations: 17

Conclusion 🎉

Dr. Sidra Naz is an exceptional candidate for the Best Researcher Award, given her strong research background, high-impact publications, and international recognition. While she could further strengthen her profile by securing independent research grants and leading more first-author studies, her diverse contributions to medical science and global health make her a highly competitive nominee.

 

 

Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Dr. Fatemeh Tajik | Cancer Biophotonics Studies | Cancer Biophotonics Award

Assistant Specialist at University of California Irvine Medical Center, United States

Dr. Fatemeh Tajik is an accomplished medical researcher dedicated to advancing cancer diagnostics. She earned her MD in 2021, ranking among the top 1% of her class. Since then, she has been engaged in groundbreaking research on cancer biomarkers, particularly circulating extracellular vesicle biomarkers for peritoneal carcinomatosis. Currently serving as an Assistant Specialist at the University of California, Irvine, Dr. Tajik contributes significantly to translational and clinical research, with the goal of improving patient outcomes.

Profile

ORCID

Education 🎓

Dr. Tajik completed her Doctor of Medicine (MD) in 2021. Her academic excellence placed her among the top 1% of her graduating class. Her advanced studies and research focus on cancer biomarker identification, leading to significant contributions in oncology.

Experience 🌟

From 2021 to 2023, Dr. Tajik dedicated her research to identifying novel cancer biomarkers, culminating in multiple peer-reviewed publications. In 2023, she joined the Department of Surgery at the University of California, Irvine, where she specializes in translational cancer research. Additionally, she serves as a reviewer for esteemed journals and has co-authored a book chapter, further demonstrating her expertise and commitment to the field.

Research Interests 🌿

Dr. Tajik’s research revolves around cancer biology, with a specific focus on:

  • Cancer biomarkers
  • Extracellular vesicles
  • Peritoneal carcinomatosis Her work aims to refine predictive and prognostic tools for cancer, significantly impacting early detection and treatment approaches.

Awards 🏆

Dr. Tajik has been recognized for her contributions to cancer research and innovation. She has been nominated for prestigious awards such as the Excellence in Research Award and the Best Researcher Award, highlighting her significant impact on the field.

Publications 📚

Dr. Tajik has published extensively in high-impact journals. Her notable publications include:

“Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis”

  • Journal: Cancers
  • Publication Date: January 17, 2025
  • DOI: 10.3390/cancers17020289

“Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease”

  • Journal: Journal of Gastrointestinal Cancer
  • Publication Date: June 2024
  • DOI: 10.1007/s12029-023-00994-5

“Transformation of Chronic Lymphocytic Leukemia into Acute Mixed Phenotype Leukemia Myeloid/T Neoplasm: a Case Report”

  • Journal: SN Comprehensive Clinical Medicine
  • Publication Date: September 11, 2023
  • DOI: 10.1007/s42399-023-01567-0

“Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis”

  • Journal: BMJ Supportive & Palliative Care
  • Publication Date: June 2023
  • DOI: 10.1136/bmjspcare-2021-003125

“A comprehensive Examination of the potential application of Chat GPT in Higher Education Institutions”

  • Type: Preprint
  • Publication Date: April 12, 2023
  • DOI: 10.36227/techrxiv.22589497.v1

“Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report”

  • Type: Preprint
  • Publication Date: January 27, 2023
  • DOI: 10.21203/rs.3.rs-2516078/v1

“Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends”

  • Journal: Journal of Surgical Oncology
  • Publication Date: 2023
  • DOI: 10.1002/jso.27448

“Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis”

  • Journal: Cancer Cell International
  • Publication Date: 2023
  • DOI: 10.1186/s12935-023-02851-8

“Clinical significance of CD166 and HER-2 in different types of gastric cancer”

  • Journal: Clinical and Translational Oncology
  • Publication Date: 2023
  • DOI: 10.1007/s12094-023-03297-0

“COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review”

  • Journal: BMJ Supportive and Palliative Care
  • Publication Date: 2023
  • DOI: 10.1136/spcare-2023-004310

Conclusion 🏅

Fatemeh Tajik is a highly qualified candidate for the Research for Cancer Biophotonics Award due to her impressive research output, strong academic background, and impactful work in cancer diagnostics. However, to make her application more competitive, she should highlight her direct contributions to biophotonics, expand her involvement in industry collaborations, and clearly outline her most significant scientific innovations.